fda green list import alert 66-80 glp-1 apis introduces "Green List" for drug ingredients | Bob Durkin posted on the topic FDA's Concerns with Unapproved GLP-1

One of the relevant exclusivity periods applies to New Drug Applications (NDA) for approved products containing new chemical entities (NCEs), whereby an ANDA with a paragraph IV certification may not be submitted until four years after the NDA was approved (i.e., the NCE-1 date)

Bio-Carnitina is contraindicated in patients with known hypersensitivity to any of the components of the formula

It is illegal to advertise prescription medication in Australia

DSIP (Delta Sleep-Inducing Peptide) is not a licensed medicine or drug and has not been approved by the MHRA, FDA, or any regulatory authority for use in humans or animals